SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $6,483,000 | -24.1% | 114,119 | 0.0% | 0.21% | -28.2% |
Q1 2021 | $8,542,000 | -35.1% | 114,119 | -24.9% | 0.29% | -36.4% |
Q4 2020 | $13,153,000 | +123.7% | 152,040 | +58.0% | 0.46% | +110.0% |
Q3 2020 | $5,880,000 | +47.0% | 96,211 | 0.0% | 0.22% | +44.7% |
Q2 2020 | $4,000,000 | +44.8% | 96,211 | 0.0% | 0.15% | +21.6% |
Q1 2020 | $2,763,000 | -60.2% | 96,211 | 0.0% | 0.12% | -52.5% |
Q4 2019 | $6,945,000 | -43.0% | 96,211 | +10.9% | 0.26% | -50.5% |
Q3 2019 | $12,174,000 | -21.0% | 86,780 | +3.1% | 0.53% | -15.6% |
Q2 2019 | $15,406,000 | +21.3% | 84,145 | +5.4% | 0.63% | +21.9% |
Q1 2019 | $12,701,000 | +34.7% | 79,856 | -18.9% | 0.52% | +27.7% |
Q4 2018 | $9,430,000 | -53.5% | 98,444 | -31.5% | 0.40% | -45.1% |
Q3 2018 | $20,285,000 | -9.8% | 143,614 | 0.0% | 0.74% | -13.7% |
Q2 2018 | $22,480,000 | +12.0% | 143,614 | +15.2% | 0.85% | +9.2% |
Q1 2018 | $20,077,000 | +79.7% | 124,650 | +83.8% | 0.78% | +81.2% |
Q4 2017 | $11,170,000 | +55.0% | 67,815 | -25.0% | 0.43% | +61.4% |
Q2 2017 | $7,206,000 | +12.1% | 90,480 | 0.0% | 0.27% | +7.2% |
Q1 2017 | $6,430,000 | +133.2% | 90,480 | +67.6% | 0.25% | +112.8% |
Q4 2016 | $2,757,000 | -59.2% | 54,000 | -63.2% | 0.12% | -55.0% |
Q3 2016 | $6,760,000 | +52.8% | 146,800 | 0.0% | 0.26% | +43.6% |
Q2 2016 | $4,423,000 | -6.0% | 146,800 | 0.0% | 0.18% | -9.5% |
Q1 2016 | $4,706,000 | -17.5% | 146,800 | +50.1% | 0.20% | -3.4% |
Q4 2015 | $5,702,000 | -25.4% | 97,800 | -45.8% | 0.21% | -24.7% |
Q3 2015 | $7,643,000 | +598.0% | 180,600 | +1104.0% | 0.28% | +587.5% |
Q2 2015 | $1,095,000 | +45.4% | 15,000 | 0.0% | 0.04% | +33.3% |
Q1 2015 | $753,000 | +311.5% | 15,000 | +200.0% | 0.03% | +233.3% |
Q4 2014 | $183,000 | +15.8% | 5,000 | 0.0% | 0.01% | +28.6% |
Q3 2014 | $158,000 | – | 5,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
Diametric Capital, LP | 19,393 | $626,000 | 0.46% |